Van Berkom & Associates Inc. Trims Stock Position in Maximus, Inc. $MMS

Key Points

• Van Berkom & Associates trimmed its Maximus stake by 2.7% (sold 30,797 shares), leaving it with 1,130,328 shares worth about $97.6M and making MMS its eighth-largest holding; overall institutional ownership is very high at ~97.2% with several other large funds increasing positions.
• Research firms have recently downgraded MMS to a consensus "Hold", while the stock is down ~1.6%; fundamentals show a slight EPS beat ($1.85 vs. $1.84) but a 4.1% revenue decline and FY2026 guidance of 8.05–8.35 EPS (analyst average ~8.46).
• Maximus declared a quarterly dividend of $0.33 (annualized yield ~2.0%, ex-dividend May 15), and insiders showed mixed activity as the CFO bought 1,000 shares while a director sold 742, with total insider ownership at ~1.8%.

Van Berkom & Associates Inc. cut its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 2.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,130,328 shares of the health services provider's stock after selling 30,797 shares during the period. Maximus makes up approximately 2.8% of Van Berkom & Associates Inc.'s investment portfolio, making the stock its 8th largest holding. Van Berkom & Associates Inc. owned 2.07% of Maximus worth $97,570,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in MMS. JPMorgan Chase & Co. raised its stake in shares of Maximus by 19.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider's stock worth $18,304,000 after purchasing an additional 33,136 shares during the period. Divisadero Street Capital Management LP boosted its position in shares of Maximus by 93.5% during the third quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider's stock valued at $16,800,000 after buying an additional 88,872 shares during the last quarter. Stephens Investment Management Group LLC boosted its position in Maximus by 49.0% in the third quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider's stock worth $65,873,000 after purchasing an additional 237,097 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Maximus by 2.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider's stock valued at $170,812,000 after purchasing an additional 36,989 shares during the period. Finally, WINTON GROUP Ltd bought a new position in shares of Maximus during the 3rd quarter valued at approximately $6,208,000. 97.21% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

MMS has been the topic of a number of research reports. Weiss Ratings lowered Maximus from a "buy (b)" rating to a "hold (c+)" rating in a report on Tuesday, February 24th. Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research note on Monday, February 23rd. Finally, Zacks Research lowered shares of Maximus from a "strong-buy" rating to a "hold" rating in a report on Monday, April 27th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold".

Maximus Stock Down 1.6%

NYSE MMS opened at $64.51 on Tuesday. The stock has a market cap of $3.52 billion, a PE ratio of 9.82 and a beta of 0.60. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.34 and a current ratio of 2.34. Maximus, Inc. has a twelve month low of $60.75 and a twelve month high of $100.00. The firm has a 50-day simple moving average of $69.28 and a 200 day simple moving average of $80.41.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping analysts' consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.37 billion. During the same period last year, the firm posted $1.61 earnings per share. The business's quarterly revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, research analysts forecast that Maximus, Inc. will post 8.46 EPS for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend is Friday, May 15th. Maximus's dividend payout ratio (DPR) is presently 20.09%.

Insider Transactions at Maximus

In related news, CFO David Mutryn purchased 1,000 shares of the business's stock in a transaction on Monday, February 9th. The stock was acquired at an average price of $75.62 per share, with a total value of $75,620.00. Following the purchase, the chief financial officer directly owned 40,037 shares in the company, valued at approximately $3,027,597.94. This represents a 2.56% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jan Madsen sold 742 shares of the business's stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the transaction, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. The trade was a 3.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 1.80% of the company's stock.

Maximus Company Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.